LTGO · Latigo Biotherapeutics, Inc.
$23.04
+0.56 (+2.49%)
At close · Sep 4
Going-concern doubt
— cleared Sep 3, 2026
The latest filing states the doubt was alleviated.
“Accordingly, the prior substantial doubt about the Company's ability to continue as a going concern has been alleviated.”View the 10-Q filed Sep 3, 2026
Market Cap
$1.53B
Shares
66.30M
Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.
Short Volume
| Date | Short Volume | Short Exempt | Total Volume | Short % |
|---|---|---|---|---|
| 2026-09-04 | 29,773 | 0 | 85,372 | 34.9% |
| 2026-09-03 | 52,242 | 0 | 111,952 | 46.7% |
| 2026-09-02 | 22,654 | 0 | 53,334 | 42.5% |
| 2026-09-01 | 38,530 | 1,562 | 112,389 | 34.3% |
| 2026-08-31 | 17,425 | 0 | 56,764 | 30.7% |
| 2026-08-28 | 75,132 | 0 | 130,691 | 57.5% |
| 2026-08-27 | 43,288 | 0 | 101,747 | 42.5% |
| 2026-08-26 | 19,495 | 0 | 49,584 | 39.3% |
| 2026-08-25 | 22,320 | 0 | 79,242 | 28.2% |
| 2026-08-24 | 58,018 | 0 | 101,698 | 57.0% |
| 2026-08-21 | 32,238 | 0 | 104,240 | 30.9% |
| 2026-08-20 | 9,643 | 0 | 44,620 | 21.6% |
| 2026-08-19 | 23,835 | 0 | 65,324 | 36.5% |
| 2026-08-18 | 62,000 | 0 | 120,732 | 51.4% |
| 2026-08-17 | 27,714 | 0 | 73,397 | 37.8% |
| 2026-08-14 | 60,173 | 0 | 128,125 | 47.0% |
| 2026-08-13 | 38,453 | 0 | 103,115 | 37.3% |
| 2026-08-12 | 32,737 | 0 | 113,541 | 28.8% |
| 2026-08-11 | 22,717 | 0 | 116,318 | 19.5% |
| 2026-08-10 | 78,039 | 0 | 350,774 | 22.2% |
| 2026-08-07 | 337,597 | 0 | 1,205,046 | 28.0% |
Showing 1–21 of 21 days